Gilead Sciences, Inc. - Jul 28, 2022 Form 3 Insider Report for Allovir, Inc. (ALVR)

Role
10%+ Owner
Signature
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson, Chief Financial Officer
Stock symbol
ALVR
Transactions as of
Jul 28, 2022
Transactions value $
$0
Form type
3
Date filed
8/5/2022, 05:45 PM
Previous filing
Feb 17, 2022
Next filing
Jun 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALVR Common Stock 13.7M Jul 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.